Literature DB >> 31356865

Novel role of the SRY-related high-mobility-group box D gene in cancer.

Zhenxing Liang1, Jing Xu2, Chunhu Gu3.   

Abstract

The SRY-related high-mobility-group box (Sox) gene family encodes a set of transcription factors and is defined by the presence of highly conserved domains. The Sox gene can be divided into 10 groups (A-J). The SoxD subpopulation consists of Sox5, Sox6, Sox13 and Sox23, which are involved in the transcriptional regulation of developmental processes, including embryonic development, nerve growth and cartilage formation. Recently, the SoxD gene family was recognized as important transcriptional regulators associated with many types of cancer. In addition, Sox5 and Sox6 are representatives of the D subfamily, and there are many related studies; however, there are few reports on Sox13 and Sox23. In this review, we first introduce the structures of the SoxD genes. Next, we summarize the latest research progress on SoxD in various types of cancer. Finally, we discuss the potential direction of future SoxD research. In general, the information reviewed here may contribute to future experimental design and increase the potential of SoxD as a cancer treatment target.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Epithelial-mesenchymal transition; Sox13; Sox5; Sox6

Year:  2019        PMID: 31356865     DOI: 10.1016/j.semcancer.2019.07.011

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  10 in total

1.  SOX13 regulates cancer stem-like properties and tumorigenicity in hepatocellular carcinoma cells.

Authors:  Hui Jiao; Fei Fang; Ting Fang; Yuting You; Min Feng; Xiaomin Wang; Zhenyu Yin; Wenxiu Zhao
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

2.  Bioinformatics analysis of SOXF family genes reveals potential regulatory mechanism and diagnostic value in cancers.

Authors:  Dan Wu; Chuan Jiang; Jing-Jing Zheng; De-Sheng Luo; Ji Ma; Hai-Feng Que; Chao Li; Chao Ma; Hui-Yong Wang; Wei Wang; Hong-Tao Xu
Journal:  Ann Transl Med       Date:  2022-06

3.  CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis.

Authors:  Yaming Li; Jinzhao Zhang; Shuang Pan; Jing Zhou; Xin Diao; Song Liu
Journal:  Thorac Cancer       Date:  2020-01-09       Impact factor: 3.500

Review 4.  Emerging roles of Sox6 in the renal and cardiovascular system.

Authors:  Mohammad Saleem; Pierina Barturen-Larrea; Jose A Gomez
Journal:  Physiol Rep       Date:  2020-11

5.  The Human Positive Cofactor 4 is a Promising Chemotherapeutic Target in Lung Adenocarcinoma.

Authors:  Tianyu Sun; Jingge Zhang; Xiaoqing Fan; Tan Long; Shaolin Tao; Poming Kang; Qunyou Tan
Journal:  J Oncol       Date:  2021-12-03       Impact factor: 4.375

6.  Identification of SOX6 and SOX12 as Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma: A Retrospective Study Based on TCGA Database.

Authors:  Xiao Lyu; Xi Zhang; Li-Bin Sun; Xiao-Ming Cao; Xu-Hui Zhang
Journal:  Dis Markers       Date:  2021-11-26       Impact factor: 3.434

Review 7.  Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy.

Authors:  Xiangyuan Luo; Xiaoyu Ji; Meng Xie; Tongyue Zhang; Yijun Wang; Mengyu Sun; Wenjie Huang; Limin Xia
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639

8.  N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance.

Authors:  Xian Lin; Feng Wang; Jian Chen; Jing Liu; Yi-Bin Lin; Li Li; Chuan-Ben Chen; Qin Xu
Journal:  Mil Med Res       Date:  2022-04-14

9.  Sox13 is a novel flow-sensitive transcription factor that prevents inflammation by repressing chemokine expression in endothelial cells.

Authors:  Catherine Demos; Janie Johnson; Aitor Andueza; Christian Park; Yerin Kim; Nicolas Villa-Roel; Dong-Won Kang; Sandeep Kumar; Hanjoong Jo
Journal:  Front Cardiovasc Med       Date:  2022-09-30

10.  Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.

Authors:  Min Zhou; Xiuli Zhang; Chang Liu; Danian Nie; Shuyi Li; Peilong Lai; Yanli Jin
Journal:  Oncogene       Date:  2021-04-30       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.